Radiofrequency Ablation of Metastatic Lesions in Adrenocortical Cancer
Authors: Jame Abraham
Journal: Annals of Internal Medicine (2000)

Letters15 August 2000Radiofrequency Ablation of Metastatic Lesions in Adrenocortical CancerJame Abraham, MD, Tito Fojo, MD, PhD, and Bradford J. Wood, MDJame Abraham, MDNational Institutes of Health; Bethesda, MD 20892 (Abraham)National Institutes of Health; Bethesda, MD 20892 (Fojo)National Institutes of Health; Bethesda, MD 20892 (Wood), Tito Fojo, MD, PhDNational Institutes of Health; Bethesda, MD 20892 (Abraham)National Institutes of Health; Bethesda, MD 20892 (Fojo)National Institutes of Health; Bethesda, MD 20892 (Wood), and Bradford J. Wood, MDNational Institutes of Health; Bethesda, MD 20892 (Abraham)National Institutes of Health; Bethesda, MD 20892 (Fojo)National Institutes of Health; Bethesda, MD 20892 (Wood)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-133-4-200008150-00028 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Adrenocortical cancer has an estimated annual incidence of one to two cases per million in the United States and a 5-year survival rate of 20% to 25%. Patients with metastatic disease may benefit from repeated surgical resection, but the associated morbidity and cost can be high (1-3). Radiofrequency ablation is safe and effective for the local control of unresectable hepatic neoplasms and has a complication rate of 2.5% (4, 5).As an alternative to surgery, we performed radiofrequency ablation eight times in four patients with metastatic adrenocortical cancer [Table]. Radiofrequency ablation was performed with intravenous midazolam, intravenous ...References1. Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, et al . Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med. 1990;332:1195-201. CrossrefGoogle Scholar2. Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery. 1992;112:963-71. MedlineGoogle Scholar3. Jensen JC, Pass HI, Sindelar WF, Norton JA. Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Aggressive resection vs chemotherapy. Arch Surg. 1991;126:457-61. CrossrefMedlineGoogle Scholar4. Solbiati L, Ierace T, Goldberg SN, Sironi S, Livraghi T, Fiocca R, et al . Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology. 1997;202:195-203. CrossrefMedlineGoogle Scholar5. Goldberg SN, Solbiati L, Hahn PF, Cosman E, Conrad JE, Fogle R, et al . Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology. 1998;209:371-9. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: National Institutes of Health; Bethesda, MD 20892 (Abraham)National Institutes of Health; Bethesda, MD 20892 (Fojo)National Institutes of Health; Bethesda, MD 20892 (Wood) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByLong‐term outcomes in patients with advanced adrenocortical carcinoma after image‐guided locoregional ablation or embolizationResection of Adrenocortical Carcinoma Liver Metastasis: Is it Justified?Surgery of the Adrenal GlandsRadiofrequency ablation for renal tumors: Our experienceSite-Directed Therapy for Lung Cancer MetastasesNeedlescopic ablation of small adrenal massesCT-guided Radiofrequency Ablation in the Palliative Treatment of Recurrent Advanced Head and Neck MalignanciesManagement of Advanced Abdominopelvic Tumors with Combined Radiofrequency Ablation and Surgical DebulkingPercutaneous radiofrequency ablation of renal tumours: Case series of 11 tumours and review of published workImage-Guided Radiofrequency Ablation for Adrenocortical Adenoma with Cushing Syndrome: Outcomes After Mean Follow-up of 33 MonthsCombined radiofrequency-surgical debulking of advanced abdomino-pelvic tumorsRenal Tumors: Technical Success and Early Clinical Experience with Radiofrequency Ablation of 18 TumorsA review of the general aspects of radiofrequency ablationLocal Recurrence After Hepatic Radiofrequency CoagulationRadiofrequency ablation for malignant liver tumorLife-Threatening Hypertensive Crises in Two Patients Undergoing Hepatic Radiofrequency AblationRadiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastasesAdrenal-preserving minimally invasive surgery: The role of laparoscopic partial adrenalectomy, cryosurgery, and radiofrequency ablation of the adrenal glandRadiofrequency ablation of hepatic metastasesPercutaneous tumor ablation with radiofrequencyRadiofrequency Ablation for Percutaneous Treatment of Malignant Renal TumorsInoperable Abdomino-Pelvic Tumors: Treatment with Radio-Frequency Ablation and Surgical DebulkingRadiofrequency Ablation 15 August 2000Volume 133, Issue 4Page: 312-313KeywordsLesionsLiverMorbidityNecrosisOutpatientsProteinsRadiofrequency ablationSurgerySurgical resectionTemperature ePublished: 15 August 2000 Issue Published: 15 August 2000 CopyrightCopyright © 2000 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...